Do I need to start heparin (unfractionated heparin or low molecular weight heparin) for anticoagulation when holding warfarin (coumarin) due to a procedure if the International Normalized Ratio (INR) is within the therapeutic range?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bridging Anticoagulation Timing for Warfarin Interruption

Start heparin bridging therapy immediately when warfarin is held, without waiting for the INR to become subtherapeutic. 1, 2

When to Initiate Bridging Therapy

For high-risk patients (mechanical heart valves, recent VTE <3 months, atrial fibrillation with prior stroke), bridging anticoagulation with therapeutic-dose heparin (UFH or LMWH) should begin 1-2 days after stopping warfarin, not after the INR drops below therapeutic range. 1

The specific timing is:

  • Stop warfarin 5 days before the procedure 1
  • Start LMWH 2 days after stopping warfarin (1 day after acenocoumarol) 1
  • Do not wait for INR to become subtherapeutic before starting bridging 1, 2

Rationale for Early Bridging Initiation

The critical concept here is that warfarin has a half-life of approximately 42 hours, and therapeutic anticoagulation wanes progressively after discontinuation. 2 Waiting until the INR drops below 2.0 creates an unprotected window where the patient has inadequate anticoagulation but no bridging coverage. 2

Bridging therapy is designed to provide continuous anticoagulation coverage during the entire period when warfarin effect is declining and subtherapeutic. 1

High-Risk vs Low-Risk Patients

High-Risk Patients Requiring Bridging 1:

  • Mechanical heart valves (especially mitral position or older-generation valves) 1
  • Atrial fibrillation with prior stroke/TIA or CHA₂DS₂-VASc ≥2 1
  • Recent VTE (<3 months) 1
  • Thrombophilia or hypercoagulable conditions 1

Low-Risk Patients (No Bridging Needed) 1:

  • Bileaflet mechanical AVR without additional risk factors 1
  • Can simply hold warfarin 5 days before procedure without bridging 1

Specific Bridging Protocol

For patients requiring bridging: 1, 2

  1. Stop warfarin 5 days (5 doses) before surgery 1
  2. Start therapeutic-dose LMWH 2 days after stopping warfarin 1
    • Enoxaparin 1 mg/kg subcutaneous every 12 hours 2
    • Target anti-Xa level 0.8-1.2 U/mL 2
  3. Give last dose of LMWH at least 12-24 hours before the procedure 1
  4. Check INR on day of procedure (should be <1.5) 1

Postoperative Resumption

Resume warfarin on the evening of surgery (day 1-2 postoperatively) at the usual maintenance dose. 1, 2, 3

Restart therapeutic-dose LMWH or UFH 12-48 hours after surgery depending on bleeding risk and hemostatic stability. 1, 4

  • Low bleeding risk procedures: restart at 12-24 hours 4
  • High bleeding risk procedures: restart at 48-72 hours 1, 4

Continue bridging therapy until INR returns to therapeutic range (typically 4-5 days of overlap). 1, 2, 5, 3

Common Pitfalls to Avoid

Do not wait for a subtherapeutic INR before starting bridging—this creates a dangerous gap in anticoagulation coverage. 2 The entire point of bridging is to maintain anticoagulation during the transition period when warfarin is wearing off.

Do not restart therapeutic-dose heparin too early postoperatively in high bleeding risk procedures—this significantly increases bleeding complications. 1, 4 Prophylactic-dose heparin can be given at 12 hours, but therapeutic dosing should wait 48-72 hours if bleeding risk is high. 1, 4

For mechanical valves, never skip bridging therapy—these patients are at extremely high risk for valve thrombosis during even brief periods without anticoagulation. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Warfarin Resumption After Interruption in Valve Replacement Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Restarting Heparin Prophylaxis After PEG Tube Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Warfarin and Heparin Overlap Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is it safer to continue dalteparin (low molecular weight heparin) in a patient with low albumin rather than switching to warfarin (coumarin anticoagulant)?
Would a patient with a high bleeding risk score and high Venous Thromboembolism (VTE) risk require bridging when switching from Fragmin (dalteparin) to warfarin?
Should heparin (unfractionated heparin) therapy be held prior to debridement in the operating room (OR) to minimize the risk of bleeding?
How long should warfarin (Coumadin) be held before a procedure?
When to use bridging anticoagulation in patients undergoing procedures that require temporary interruption of anticoagulation therapy, such as dental procedures?
What is the recommended dosage of ampicillin (Ampicillin)-sulbactam (Unasyn) for a pregnant woman with a ruptured membrane?
What is the prevalence and treatment of cataracts in the elderly?
What is the recommended treatment for a 5-year-old male with low-grade fever, mild congestion, and headache for 2-3 days, who has a history of a tick bite treated prophylactically with doxycycline (doxycycline) x 1 dose about a month ago?
What are the aggravators and remedies for seborrheic dermatitis, and does shaving facial hair help?
Why is D5 (Dextrose 5%) 0.45% NaCl (Sodium Chloride) recommended for a patient with moderate dehydration?
Is this patient's presentation more consistent with Waldenström's Macroglobulinemia (WM) or multiple myeloma, given the monoclonal B-cell immunophenotype and elevated Immunoglobulin M (IgM) level?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.